Avidity Biosciences, Inc (RNAM) — Defensive Interval Ratio
Avidity Biosciences, Inc (RNAM) has a Defensive Interval Ratio of 2478 days as of December 2025. Defensive assets of $1.33 Billion (cash $-, short-term investments $1.31 Billion, receivables $12.44 Million) cover 2478 days of daily cash needs of $535.47K/day. See RNAM working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Avidity Biosciences, Inc Defensive Interval Ratio (2020–2025)
This chart shows how Avidity Biosciences, Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the ratio stands at 2478 days, meaning defensive assets of $1.33 Billion can fund 2478 days of operations without new revenue. See Avidity Biosciences, Inc (RNAM) net asset quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Avidity Biosciences, Inc (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Avidity Biosciences, Inc from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see RNAM company net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2478 days | $1.33 Billion | $535.47K/day | $- | $1.31 Billion | ▼ -2295 days |
| 2024 | 4773 days | $1.28 Billion | $268.54K/day | $- | $1.28 Billion | ▲ +2908 days |
| 2023 | 1865 days | $412.17 Million | $221.04K/day | $- | $410.27 Million | ▼ -51 days |
| 2022 | 1916 days | $272.43 Million | $142.21K/day | $- | $270.33 Million | ▲ +857 days |
| 2021 | 1058 days | $86.00 Million | $81.25K/day | $- | $85.09 Million | ▲ +861 days |
| 2020 | 197 days | $7.88 Million | $39.96K/day | $- | $6.68 Million | — |